Breaking News

India Responds to IP Issues Raised Over Novartis Case
Download PDF
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading...

On his visit to the World Intellectual Property Organization in Geneva, India’s Trade Minister Anand Sharma gave some straightforward answers and raised some cogent issues. The tirade over intellectual property rights raised by pharmaceutical companies after the top court in India denied Novartis’ bid for patent protection on its cancer drug, Glivec, was addressed by Sharma.

The first thing Sharma said was that India’s government had never exercised its executive power to compel any company to make cheap drugs available. However, India reserved its right to do so, if and whenever the government feels such a step is required.

While admitting that protection of intellectual property rights was a critical question, Sharma observed, “What is good, to allow people to die or to make the medicine available? That’s the larger question.”

  
What
Where


Sharma said that Novartis had “absolutely no reason to complain” against the India government because the case was decided by the independent judiciary and not by the executive wing of the government.

Sharma further stressed that India was a source of a huge amount of intellectual property and had an interest in protecting such property, and as such was respectful of the same when it came to others. He said the Glivec decision would not affect investment into India.

However, Sharma stressed that the court decision to deny Novartis patent protection for Glivec was absolutely justified under the intellectual property rules of the World Trade Organization. He said, the rules, also known as the TRIPS agreement contains “a flexibility that has been negotiated and integral” to TRIPS, and developed countries often use the right to compulsory licensing.

Get JD Journal in Your Mail

Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!




In fact, Sharma drew attention to the fact that developed countries had used the right to compulsory licensing at least 160 times, within which more than 63 times, the power was used by the executive. So, when it came to developing countries, they had the right to make available affordable medicines in response to life-threatening diseases or epidemics.





 

RELEVANT JOBS

Divorce Mediation Attorney

USA-MA-Boston

I am an experienced divorce mediator (27 years) and solo practitioner approaching retirement. I...

Apply now

Paralegal - Torts & Insurance Litigation

USA-FL-Fort Myers

Henderson Franklin is currently accepting resumes for skilled paralegals in our Torts and Insur...

Apply now

Family Law Attorney

USA-CA-Beverly Hills

Prominent family law firm in Beverly Hills is seeking an experienced attorney with a minimum of five...

Apply now

Associate Attorney, Litigation

USA-FL-West Palm Beach

WEST PALM BEACH AV RATED FIRM SEEKING A JR. ASSOCIATE ATTORNEY WITH 3-5 YEARS COMMERCIAL LITIGATION ...

Apply now

BCG FEATURED JOB

Locations:

Keyword:



Search Now

Litigation Associate Attorney

USA-CA-Los Angeles

Los Angeles office of a BCG Attorney Search Top Ranked Law Firm seeks a litigation associate attorne...

Apply Now

Corporate Transactional Partner

USA-CA-Los Angeles

Los Angeles office of a BCG Attorney Search Top Ranked Law Firm seeks a corporate transactional part...

Apply Now

Corporate Transactional Partner

USA-TX-Austin

Austin office of a BCG Attorney Search Top Ranked Law Firm seeks a corporate transactional partner w...

Apply Now

SEARCH IN ARCHIVE

To Top